Close

Add to pipeline

Save Close
You are viewing a limited version of this profile. To access i3's full capabilities.
Cibus
Save
Company logo (jpg or png)
Parent company
Edit alternate names

Short description

Developer of crops with environmentally friendly traits that does not use foreign genetic material

Founded in 2001
Founded in

Company type Private Public (CBUS)
Company type

Industry Group agriculture & food

Sector crop inputs

TRL Range 4-6
TRL 1 Basic research
TRL 2 Technology formulation
TRL 3 Applied research
TRL 4 Small scale prototype
TRL 5 Large scale prototype
TRL 6 Prototype system
TRL 7 Demonstration system
TRL 8 First of a kind commercial system
TRL 9 Full commercial application
TRL Range

Ticker

Headquarters San Diego, CA San Diego, United States
Address
City
State
Zip
Country

Parent Companies

Website

Updated by Cleantech Group on 06/25/2024

Traction
  • 1 M&A items
tags
Similar companies
Customers
Save
Add Customer
Date Company
Partnerships
Save
Add Partnership
Date Partner Type
12/14/2010
Rotam Global AgroSciences Rotam Global AgroSciences
Under the terms of the collaboration, Rotam will provide herbicides aligned with the value-added canola traits Cibus is developing.
View source    
Confirmed by Rotam Global AgroSciences
Channel Partner
Delete
Investment Rounds
Save

IPO INFORMATION

Date

05/31/2019

IPO status

Withdrawn

IPO Type

IPO

Amount

Initial shares

Ticker symbol

CBUS

Exchange listed

NASDAQ

Prospectus URL

Prospectus

Source URL

Source

Description

Cibus withdrew its filing in May 2019 Cibus Ltd, a provider of advanced plant-breeding technologies had priced its IPO of over 6.6 million shares at between $14 and $16 per share. The company reported a $30 million net loss on $2.6 million in revenue for the first nine months of 2018. Morgan Stanley and BofA Merrill Lynch were lead underwriters.

Cancel Save
Add Investment
Date Investors Type Amount
06/13/2024 (0)
Post-money valuation of
The funding will develop new and existing seed traits, and to fund operations at the company’s Trait Machine end-to-end gene editing facility. Cibus has agreed to sell 1,298,040 shares of its Class A Common Stock for $10 per share, except for shares of Class A Common Stock purchased by the CEO at $10.2 per share
 Follow-on Public Offering $130,000,000
Delete
Click to add IPO information
Products
Save
Add Product
Product image Name Product status Revenue model Cost metrics
You are viewing a limited version of this profile. To access i3's full capabilities.
Back to top

Preload svg text font